These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. IgG subclass distribution in organ specific autoantibodies. The relationship to complement fixing ability. Dean BM; Bottazzo GF; Cudworth AG Clin Exp Immunol; 1983 Apr; 52(1):61-6. PubMed ID: 6345036 [TBL] [Abstract][Full Text] [Related]
5. Characterization of anti-liver kidney microsomal antibody in childhood autoimmune chronic active hepatitis: evidence for IgG1 subclass restriction, polyclonality and non cross-reactivity with hepatocyte surface antigens. Peakman M; Lobo-Yeo A; Mieli-Vergani G; Davies ET; Mowat AP; Vergani D Clin Exp Immunol; 1987 Sep; 69(3):543-9. PubMed ID: 3665184 [TBL] [Abstract][Full Text] [Related]
6. [Cytoplasmic islet-cell antibodies (ICA) and cytoplasmic complement- fixing antibodies (CF-ICA) in patients with newly detected and short-lasting diabetes mellitus type 1]. Majkowska L; Czekalski S; Skwira J Pol Tyg Lek; 1990 May 7-14; 45(19-20):384-8. PubMed ID: 2255656 [TBL] [Abstract][Full Text] [Related]
7. [Detection of antibodies against pancreatic islet cells in clinical practice]. Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715 [TBL] [Abstract][Full Text] [Related]
8. Detection of islet cell surface antibodies using cloned beta cells and comparison of their incidence with that of islet cell cytoplasmic antibodies. Grant AM; Harrison DE; Moysey L; Smith D; Ashcroft SJ Diabetes Res; 1985 Sep; 2(5):225-9. PubMed ID: 3905186 [TBL] [Abstract][Full Text] [Related]
9. [Islet cell cytoplasmic antibodies (ICA) and complement-fixing islet cell cytoplasmic antibodies (CF-ICA) in patients with newly detected type 1 diabetes mellitus of short duration]. Majkowska L Ann Acad Med Stetin; 1990; 36():95-111. PubMed ID: 2099111 [TBL] [Abstract][Full Text] [Related]
10. Cytoplasmic islet cell antibodies in type I diabetics in Israel and their first-degree relatives. Assa S; Karp M; Erster B; Laron Z Isr J Med Sci; 1985 Sep; 21(9):727-30. PubMed ID: 3902719 [TBL] [Abstract][Full Text] [Related]
11. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children. Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086 [TBL] [Abstract][Full Text] [Related]
12. The distribution of microsomal and thyroglobulin antibody activity among the IgG subclasses. Parkes AB; McLachlan SM; Bird P; Rees Smith B Clin Exp Immunol; 1984 Jul; 57(1):239-43. PubMed ID: 6430614 [TBL] [Abstract][Full Text] [Related]
13. [Changes in the immunologic profile of newly-diagnosed diabetic patients during the first year of the disease]. Pizzul MG; Betterle C; De Campo C; Tonini G; Marinoni S; Pocecco M Pediatr Med Chir; 1988; 10(5):481-5. PubMed ID: 3071777 [TBL] [Abstract][Full Text] [Related]
14. Clinical time-course and characteristics of islet cell cytoplasmatic antibodies in childhood diabetes. Bruining GJ; Molenaar J; Tuk CW; Lindeman J; Bruining HA; Marner B Diabetologia; 1984 Jan; 26(1):24-9. PubMed ID: 6368297 [TBL] [Abstract][Full Text] [Related]
15. Islet cell antibodies and diabetes in Nigerians. Oli JM; Bottazzo GF; Doniach D Trop Geogr Med; 1981 Jun; 33(2):161-4. PubMed ID: 7025394 [TBL] [Abstract][Full Text] [Related]
16. Islet autoantibodies, nationality and gender: a multinational screening study in first-degree relatives of patients with Type I diabetes. Williams AJ; Bingley PJ; Moore WP; Gale EA; Diabetologia; 2002 Feb; 45(2):217-23. PubMed ID: 11935153 [TBL] [Abstract][Full Text] [Related]
17. Biological activity of pig islet-cell reactive IgG antibodies in xenotransplanted diabetic patients. Lindeborg E; Kumagai-Braesch M; Tibell A; Christensson B; Möller E Xenotransplantation; 2004 Sep; 11(5):457-70. PubMed ID: 15303983 [TBL] [Abstract][Full Text] [Related]
18. Immune islet killing mechanisms associated with insulin-dependent diabetes: in vitro expression of cellular and antibody-mediated islet cell cytotoxicity in humans. Charles MA; Suzuki M; Waldeck N; Dodson LE; Slater L; Ong K; Kershnar A; Buckingham B; Golden M J Immunol; 1983 Mar; 130(3):1189-94. PubMed ID: 6337213 [TBL] [Abstract][Full Text] [Related]
19. Early autoantibody responses in prediabetes are IgG1 dominated and suggest antigen-specific regulation. Bonifacio E; Scirpoli M; Kredel K; Füchtenbusch M; Ziegler AG J Immunol; 1999 Jul; 163(1):525-32. PubMed ID: 10384157 [TBL] [Abstract][Full Text] [Related]
20. [HLA-antigens and islet cell antibodies in type-1 diabetics of various age groups and their first-degree relatives]. Spinas GA; Keller U; Neri TM; Matter L; Staffelbach O; Berger W Schweiz Med Wochenschr; 1985 Jan; 115(2):48-54. PubMed ID: 3881821 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]